Supplementary Figure 3 from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens

Autor:	Erik Kupperman, Keisuke Kuida, Johnny Yang, Lilly Zhang, Zhe Nie, Sheldon Cao, Takashi Ichikawa, Takashi Sato, Tomohiro Kawamoto, Maki Hasegawa, Noriko Uchiyama, Saomi Murai, Isao Kaieda, Hitoshi Miyashita, Kouki Hikami, Kohei Honda, Yuichi Hikichi
Rok vydání:	2023
Popis:	PDF file - 130K, Anti-tumor activity of TAK-960 in MV4-11luc disseminated leukemia model.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cb82c738efd1b506e891eb7ac6552a https://doi.org/10.1158/1535-7163.22498084 Zobrazit plný text záznamu